Outcome of critically ill patients with abnormal sodium levels undergoing slow low efficiency daily dialysis therapy
Not Applicable
- Conditions
- Health Condition 1: N179- Acute kidney failure, unspecified
- Registration Number
- CTRI/2022/06/043320
- Lead Sponsor
- King George Medical University
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Open to Recruitment
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
1.Patients with age > 18 years with acute kidney injury (AKI) stage 2 and 3 as defined by KDIGO or Acute on Chronic Kidney disease for whom SLED was prescribed by the treating physician
2. Serum Na less than 135 mmol/L OR more than 145 mmol/L will be screened to be included in the study.
3. Patients with dysnatremia who undergo one session of SLED will be included only once in the study
Exclusion Criteria
1.The patients whose pre dialysis Na is between 135-145 mmol/L
2.The patients who could not complete the SLED session scheduled for 8-10 hours
3.Patients who were end stage renal disease and received dialysis before enrolment
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method 30 day all cause mortality after starting SLED in patients with dysnatremiaTimepoint: 30 days
- Secondary Outcome Measures
Name Time Method To correlate the change in Na (Pre-post) dialysis to 30 day mortality <br/ ><br> <br/ ><br>To correlate the severity of dysnatremia with 30 day mortality <br/ ><br> <br/ ><br>Factors associated with 30 day mortalityTimepoint: 30th day